Scilex Holding Company (SCLX)
Nasdaq: SCLX · Biological Products, (No Diagnostic Substances) · Palo Alto, CA · filing with the SEC since 2020
Who owns Scilex Holding Company
As filed with the SECHolders of 5% or more
1
SCLX Stock Acquisition JV LLC holds 11.4% of Common Stock, $0.0001 par value per share, as its SCHEDULE 13D/A filed Jul 7, 2026 says.
Directors and officers
5
report now, of 17 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
SCLX Stock Acquisition JV LLC
SCHEDULE 13D/A · filed Jul 7, 2026 · Common Stock, $0.0001 par value per share · 21.1% in Jan 23, 2025
Oramed Pharmaceuticals Inc.
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 9.9% in Nov 14, 2025
What SCLX reports owning in othersstakes of 5% or more, and other ties
Semnur Pharmaceuticals, Inc.
SCHEDULE 13D · filed Sep 26, 2025 · Common Stock, par value $0.0001
Semnur Pharmaceuticals, Inc.
SCHEDULE 13D/A · filed Jun 26, 2026 · Common Stock, par value $0.0001
Datavault AI Inc. DVLT
SCHEDULE 13D/A · filed Aug 24, 2026 · Common Stock, par value $0.0001 per share
Other ties the annual report names
Oramed
An entity · legal entity · owns, named in the 10-K filed Apr 10, 2026
Scilex Bio JV
An entity · legal entity · owns, named in the 10-K filed Apr 10, 2026
Semnur
An entity · legal entity · owns, named in the 10-K filed Apr 10, 2026
Vhc
An investee · investee · invested in, named in the 10-K filed Apr 10, 2026
VHC Business Combination
A company bought · acquisition · owns, named in the 10-K filed Apr 10, 2026
9 subsidiaries in 2 countries, from the list filed with the 10-K filed Apr 10, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2024 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 23 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Scilex Holding Co | 10% owner | 3 | $12.8M | 0 | 0 | $0 |